Brejová, Broňa
Boršová, Kristína
Hodorová, Viktória
Čabanová, Viktória
Reizigová, Lenka
Paul, Evan D.
Čekan, Pavol
Klempa, Boris http://orcid.org/0000-0002-6931-1224
Nosek, Jozef
Vinař, Tomáš
Funding for this research was provided by:
Agentúra na Podporu Výskumu a Vývoja (APVV-18-0239, PP-COVID-20-0017, PP-COVID-20-0116)
Slovenská Akadémia Vied (VEGA 1/0463/20)
Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR (VEGA 1/0458/18)
Horizon 2020 Framework Programme (871029)
Horizon 2020 (872539)
Article History
Received: 17 May 2021
Accepted: 13 August 2021
First Online: 27 August 2021
Declarations
:
: MultiplexDX, s.r.o. has developed and manufactured the B.1.1.7 differential RT-qPCR assay kit. Biomedical Research Center of the Slovak Academy of Sciences has entered into collaboration with MultiplexDX, s.r.o. for development and validation of RT-qPCR tests. All other authors declare no competing interests.
: All clinical specimens used within this study were previously collected for the purpose of primary diagnosis of SARS-CoV-2 by the Regional Authority of Public Health, Trenčín, Slovakia and were transferred to the Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia while made unidentifiable for the researchers performing this study. The study has been approved by the Ethics committee of Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia (Ethics Committee Statement No. EK/BmV-02/2020).